Fig. 7From: SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemnessThe role of SHP2 derived CXCL8/CXCR1 positive feedback loop in EGFR T790M mutant LUADBack to article page